MedPath

Evaluation of the efficacy of Black seed oil in the treatment of Nasal allergic inflammatio

Phase 2
Conditions
Allergic rhinitis.
Allergic rhinitis, unspecified
Registration Number
IRCT138806212446N1
Lead Sponsor
Research Deputy, Ahwaz Jondishapour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
66
Inclusion Criteria

Patients aged 15–65 years with allergic rhinitis and no consumption of steroids and antihistamines and decongestants during 4 weeks before the study
Exclusion criteria: Patients who use steroids or antihistamines and decongestants during the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IgE of serum and nasal secretion. Timepoint: at first and one month later. Method of measurement: Laboratory.
Secondary Outcome Measures
NameTimeMethod
Eosinophil count of serum and nasal secretion. Timepoint: at first and one month later. Method of measurement: Laboratory.
© Copyright 2025. All Rights Reserved by MedPath